Cargando…
Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol
INTRODUCTION: It has been argued that tapentadol may pharmacologically have lower abuse potential than other pharmaceutical opioids currently available. However, there has been no comprehensive triangulation of data regarding use and harms associated with this formulation. A sustained-release formul...
Autores principales: | Peacock, Amy, Larance, Briony, Farrell, Michael, Cairns, Rose, Buckley, Nicholas, Degenhardt, Louisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875643/ https://www.ncbi.nlm.nih.gov/pubmed/29574444 http://dx.doi.org/10.1136/bmjopen-2017-020006 |
Ejemplares similares
-
Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB study
por: Larance, Briony, et al.
Publicado: (2020) -
Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study
por: Larney, Sarah, et al.
Publicado: (2014) -
Comparing opioid types in the persistence of opioid use following surgical admission: a study protocol for a retrospective observational linkage study comparing tapentadol and oxycodone in Australia
por: Lam, Tina, et al.
Publicado: (2022) -
Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study
por: Larney, Sarah, et al.
Publicado: (2018) -
Slow release oral morphine versus methadone for the treatment of opioid use disorder
por: Klimas, Jan, et al.
Publicado: (2019)